Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in London, 4BIO Capital is a venture capital firm dedicated to the advanced therapies sector, with a strong emphasis on addressing high unmet medical needs. The firm primarily invests in early-stage companies, focusing on innovative treatments that leverage cutting-edge technologies in cell and gene therapy, RNA-based therapy, targeted therapies, and microbiome research. Although specific fund sizes and portfolio counts are not disclosed, 4BIO Capital is recognized for its strategic approach to investing in transformative healthcare solutions. The firm operates mainly within Europe and the United Kingdom, positioning itself as a key player in the biotech and healthcare investment landscape.
The leadership team at 4BIO Capital comprises experts from diverse backgrounds, including medicine, finance, and academia. This multidisciplinary expertise enables the firm to evaluate investment opportunities effectively and provide valuable support to its portfolio companies. By fostering collaboration and innovation, 4BIO Capital aims to drive advancements in healthcare that can significantly improve patient outcomes and address pressing medical challenges.
4BIO Capital's investment focus is centered on early-stage companies within the advanced therapies sector, specifically targeting areas such as cell therapy, gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The firm seeks to identify and support startups that are developing groundbreaking treatments for significant medical and social needs. By concentrating on these high-impact areas, 4BIO Capital aims to contribute to the evolution of healthcare solutions that can transform patient care and address critical health issues.
The firm’s investment strategy is characterized by a commitment to understanding the unique challenges faced by its portfolio companies. 4BIO Capital looks for founders and teams that demonstrate a strong vision, scientific expertise, and a clear pathway to commercialization. By providing not only financial backing but also strategic guidance and industry insights, 4BIO Capital enhances the potential for success among its investments. This approach ensures that the firm remains at the forefront of innovation in the biotech and healthcare sectors.
To pitch 4BIO Capital, founders should email info@4biocapital.com. It is recommended to include a concise overview of the startup, the problem it aims to solve, and the innovative solution being proposed. Clear communication of the business model and potential impact will enhance the chances of a successful pitch.
4BIO Capital invests in early-stage companies, specifically at the pre-seed, seed, and seed-plus stages. This focus allows them to support startups in their formative years, helping them to develop and refine their innovative therapies.
The firm primarily focuses on the advanced therapies sector, with particular interest in biotech and healthcare. Key areas of investment include cell therapy, gene therapy, RNA-based therapy, targeted therapies, and microbiome-related treatments.
While specific check sizes are not disclosed, 4BIO Capital targets early-stage investments, which typically range from pre-seed to seed-plus funding. This allows them to provide crucial financial support to startups as they begin their journey.
4BIO Capital operates primarily in Europe and the United Kingdom, focusing on startups that are developing innovative solutions within the advanced therapies sector.
Founders interested in pitching to 4BIO Capital can reach out via email at info@4biocapital.com. It is advisable to provide a clear overview of the business, the problem it addresses, and the proposed solution.
4BIO Capital is committed to supporting its portfolio companies beyond just financial investment. The firm leverages its team's diverse expertise to offer strategic guidance, industry insights, and connections that can help startups navigate the complexities of the biotech and healthcare sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.